Rheological Functions of Erythrocyte in ESRD

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorChang Gung Memorial Hospital

About this trial

End-stage renal disease (ESRD) disrupts erythrocyte deformability due to osmotic imbalances, oxidative stress, and uremic toxins, leading to impaired microcirculation and oxygen transport. Dysregulation of ion channels, particularly the Gardos channel, exacerbates dehydration and eryptosis, further compromising vascular integrity. Given the critical role of erythrocyte flexibility in oxygen delivery, this study investigates its relationship with aerobic capacity in ESRD patients, highlighting potential mechanisms of microvascular dysfunction

Eligibility criteria

Qualifiers

Receiving hemodialysis and medication at least for 6 weeks

Kt/V score > 1.2

Disqualifiers

Under 20 years-old

Hyperkalemia occurs within 3 month

Having orthopedic or muscular diseases

Other concerned medical, psychological or physiological diseases

Trial design

Treatments tested in this trial

  • Blood collection
  • Cardiopulmonary exercise testing (CPET)

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators